A Bold Effort to Cure HIV—Using Crispr

Health Tech startups are booming. These 11 VC investors are behind some of the hottest deals

Excision BioTherapeutics Doses First Participant in EBT-101 Phase 1/2 Trial

Ameena El-Bibany of ARTIS Ventures: 5 Things I Need To See Before Making A VC Investment

Power Exits Stealth with $7M to Ensure All Patients Have Access to Clinical Trials

Vertex to Acquire ViaCyte, With the Goal of Accelerating its Potentially Curative Programs in T1D

Mental Health Startup Meomind Launches to Improve Access to Therapy and Reduce Employee Burnout

Illumina Acquires IDbyDNA

ARTIS Ventures Pioneer Spotlight: Ann Lee-Karlon

ARTIS Ventures Pioneer Spotlight: Sara Kenkare-Mitra

Flagship-founded Tessera fuels up with $300M 'to go on a really big adventure' in gene editing

Locus’ Pac-Man-Like Precision Medicine Could Negate Antibiotic Collateral Damage

Eko expands algorithmic heart problem detection and lands $30M Series C extension

Hikma Ventures leads Series B extension in Activ Surgical

ARTIS Ventures Pioneer Spotlight: Dick Daniels